Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Mechanism EP300 inhibitors(Histone acetyltransferase p300 inhibitors), p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H63F2N11O10 |
InChIKeyILVRLRGBSSFKIE-UHFFFAOYSA-N |
CAS Registry2484739-25-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 04 Jan 2021 |